Esme-28 (
DIN 02388146), an oral contraceptive (birth control product), is being voluntarily recalled from the Canadian market by Mylan Pharmaceuticals. This action is further to their
recall of a different birth control product, Freya-28, which was recalled on August 27, 2013, after one package was found to contain a placebo pill in place of an active pill.
Health Canada has been advised by Mylan Pharmaceuticals that they have been unable to rule out the possibility that Esme-28 was impacted by the same packaging issue involving Freya-28. Therefore, as a precaution, Mylan Pharmaceuticals is expanding their recall to include Esme-28. To date, no packaging errors have been identified with Esme-28.
Packages of Esme-28 should have three rows of active (pink) pills and one row of placebo (green) pills.
Missing one or more active (pink) pills could result in reduced effectiveness for contraception, with the possibility of an unplanned pregnancy. As of August 24, 2013, no adverse reactions have been reported to Health Canada related to this issue.
Esme-28 (Lot # F5042001C)
The company has informed Health Canada that Esme-21 is not impacted. Packages of Esme-21 should only have 21 active (pink) pills.
Canadians who have purchased or used Esme-28.
Health Canada will continue to monitor the situation and update Canadians and health care practitioners should new information or products be identified.
Health Canada
(613) 957-2983
(613) 957-2991
1-866 225-0709